The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Pharmaceuticals


Subject:  Re: Ziopharm Date:  5/3/2010  2:15 PM
Author:  Smufty2 Number:  871 of 898

JMP securities has increased target from $7 to $10.
Report not yet public.
Interesting thing is that JMP is only assigning value to one of the programs. This leaves a lot of room to the upside as the clinical trials progress in the other two.

Copyright 1996-2018 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us